Kasagi K, Hidaka A, Endo K, Miyamoto S, Takeuchi R, Misaki T, Sakahara H, Konishi J
Department of Nuclear Medicine, Kyoto University, Japan.
Thyroid. 1993 Winter;3(4):315-8. doi: 10.1089/thy.1993.3.315.
A 41-year-old hyperthyroid woman visited the hospital in April 1989. She spontaneously developed hypothyroidism in August 1989 and recurrent hyperthyroidism in November 1991. TSH binding inhibitor immunoglobulins (TBII) and thyroid-stimulating antibodies (TSAb) activities were 34.7% (normal range, < 11.0%) and 295.0% (normal range, < 145.0%), respectively, at her first visit. When she was hypothyroid, TBII were 85.9-90.0%, TSAb were 75-190%, and thyroid stimulation-blocking antibodies (TSBAb) activities were 80.0-96.6% (normal range, < 32.2%). When she became hyperthyroid again, TSAb activities were markedly increased to 1108% with TBII and TSBAb activities being 82.2 and 62.8%, respectively. The results indicate that both stimulating and blocking types of TSH receptor antibodies were present in her serum and that her fluctuating thyroid function could be explained by alterations in the balance between the activities of these two types of antibodies.
一名41岁的甲状腺功能亢进女性于1989年4月就诊于我院。1989年8月她自发出现甲状腺功能减退,1991年11月又复发甲状腺功能亢进。初诊时,促甲状腺激素结合抑制性免疫球蛋白(TBII)和促甲状腺素抗体(TSAb)活性分别为34.7%(正常范围,<11.0%)和295.0%(正常范围,<145.0%)。当她甲状腺功能减退时,TBII为85.9 - 90.0%,TSAb为75 - 190%,甲状腺刺激阻断抗体(TSBAb)活性为80.0 - 96.6%(正常范围,<32.2%)。当她再次出现甲状腺功能亢进时,TSAb活性显著升高至1108%,此时TBII和TSBAb活性分别为82.2%和62.8%。结果表明,她的血清中同时存在刺激性和阻断性两种促甲状腺激素受体抗体,且其甲状腺功能的波动可以用这两种抗体活性平衡的改变来解释。